An Immunological Timeline for Pregnancy

A new study uses blood samples from pregnant women to track changes in the immune system leading up to birth, and predicts gestational age from the mothers’ immune signatures.

Written byCatherine Offord
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

ISTOCK, GRINVALDSDuring pregnancy, a woman’s immune system undergoes various changes as it balances protection against pathogens with tolerance of fetal antigens. But the timing of particular changes, and how they regulate the onset of labor, have so far been difficult to define. Now, using a combination of mass cytometry and computational modeling, researchers at Stanford University have described a “clock” for the immunological events leading up to birth. The findings were published today (September 1) in Science Immunology.

The study “has generated a vast amount of new and confirmatory data on how the immune system differs in pregnancy,” writes Lynne Sykes, a clinical lecturer at Imperial College London who was not involved in the work, in an email to The Scientist. “This methodology holds great potential for the authors to unravel the complex immunological changes that precede (and may predict) early miscarriage, preterm labour, [and] pre-eclampsia.”

Over the nine months of pregnancy, the mother’s immune system dials up parts of the innate immune response, such as the activity of natural killer cells, while dialing down significant aspects of the adaptive response, such as T-cell abundance. Failures in the regulation of these adjustments are now thought to be linked to complications in pregnancy, such ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies